High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma

Cancer Journal

Volumn 8, Issue 1, 2002, Pages 74-78

  Lu, Jiade J ^a,b   Bains, Yadvindera S ^a   Abdel Wahab, May ^a   Brandon, Alfred H ^a   Wolfson, Aaron H ^a   Raub, William A ^a   Wilkinson, Craig M ^a   Markoe, Arnold M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Bile duct carcinoma; Cholangiocarcinoma; High dose rate brachytherapy; Radiotherapy

Indexed keywords

IRIDIUM 192;

ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; EXTRAHEPATIC BILIARY DUCT CARCINOMA; FOLLOW UP; HUMAN; MEGAVOLTAGE RADIATION; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STANDARD; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; BILE DUCT TUMOR; HEPATIC DUCT; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIATION RESPONSE; RADIOGRAPHY; SURVIVAL;

BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; SURVIVAL ANALYSIS;

EID: 0036370450     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200201000-00013     Document Type: Article

References (29)

1. Haffty B, Mate T, Greenwood L et al. Malignant biliary obstruction intracavitary treatment with a high-dose-rate remote afterloading device. Radiology 1987;164:574-576.
2. Buskirk S, Gunderson L, Schild S et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg 1992;215:125-131.
3. Gunderson L, Martin J, Kvols L et al. Intraoperative and external beam irradiation + 5-FU for locally advance pancreatic cancer. Int J Radiation Oncol Biol Phys 1987;13:319.
4. Dunbar L, Adkins R, Farringer J et al. Carcinoma of the gallbladder and bile ducts. Am Surg 1983;49:94.
5. Lotze M, Flickinger J, Carr B. Hepatobiliary neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: Lippincott, 1993:883-914.
6. Pitt H, Roslyn J, Tompkins R. Surgical resection of bile duct cancer: the UCLA experience. In: Wanebo HJ, ed. Hepatic and Biliary Cancer. New York: Marcel Dekker, 1987:339-355.
7. Pilepich MV. Radiation for carcinoma of the extrahepatic bile duct and radiotherapy in carcinoma of the gallbladder. In: Wanebo HJ, ed. Hepatic and Biliary Cancer. New York: Marcel Dekker, 1987:417-427.
8. Johnson D, Safai C, Goffinet D. Malignant obstructive jaundice: treatment with external-beam and intracavitary radiotherapy. Int J Radiat Oncol Biol Phys 1985;11:411-416.
9. Hanna S, Rider W. Carcinoma of the gallbladder or extrahepatic bile ducts: the role of radiotherapy. CMAJ 1978;118:59.
10. Evander A, Fredlund P, Hoevels J et al. Evaluation of aggressive surgery in carcinoma of the extrahepatic bile ducts. Ann Surg 1980;191:23.
11. Meyers W, Scott R. Internal radiation for bile duct cancer. World J Surg 1988;12:99-104.
12. Minsky B, Wesson M, Armstrong J et al. Combined modality therapy of extrahepatic biliary system cancer. Int J Radiat Oncol Biol Phys 1990;18:1157-1163.
13. Molt P, Hopfan S, Watson R et al. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 1986;57:536-544.
14. Montemaggi P, Costamagna G, Dobelbower R et al. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma. Int J Radiat Oncol Biol Phys 1995;32:437-443.
15. Mornex F, Ardiet J, Bret P et al. Radiotherapy of high bile duct carcinoma using intracatheter iridium 192 wire. Cancer 1984;54:2069-2073.
16. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994;28:945.
17. Fritz P, Brambs H, Schraube P et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys 1994;29:855-886.
18. Veeze-Kuiijpers B, Merrwaldt J, Lam J et al. The role of radiotherapy on the treatment of bile duct carcinoma. Int Radiat Oncol Biol Phys 1990;18:63-67.
19. Fields J, Emami B. Carcinoma of the extrahepatic biliary system: results of primary and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 1987;13:331-338.
20. Kopelson G, Harisiadis L, Tretter P et al. The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 1997;37:883.
21. Gonzalez D, Gerard J, Maners A et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis 1990;10:131.
22. Flickinger J, Iwatsuki S, Starzl T et al. Radiation therapy for primary carcinoma of the extrahepatic biliary system. Cancer 1991;68:289.
23. Cameron J, Pitt H, Zinner M et al. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990;159:91-97.
24. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-38.
25. Mogavero G, Jones B, Cameron J et al. Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis: increased prevalence after radiation therapy. AJR Am J Roentgenol 1992;159:1001-1003.
26. Koyama K, Tanaka J, Sato Y. Experience in twenty patients with carcinoma of the hilar bile duct treated by resection, targeting chemotherapy and intracavitary irradiation. Surg Gynecol Obstet 1993;176:239-245.
27. McMasters KM, Tuttle TM, Leach SD et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997;19/74:605-608.
28. Falkson G, MacIntyre J, Moertel C. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1983;54:965.
29. Smith GW, Bukowski RM, Hewlett JS et al. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma. Cancer 1984;54:1513-1516.